Finance

Lists
Why is COCH down 3,35%?
Dive Deeper
COCH:NASDAQ
Envoy Medical Inc
0,64 $
-3,35%
(-0,022) 1D
14 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COCH...
Open
0,65 $
High
0,66 $
Low
0,62 $
Mkt. cap
49,28 млн
Avg. vol.
62,80 мың
Volume
104,91 м.
52-wk high
0,95 $
52-wk low
0,38 $
EPS
-0,78 $
Beta
1,97
Shares outstanding
77,40 млн
No. of employees
45
Open
0,65 $
High
0,66 $
Low
0,62 $
Mkt. cap
49,28 млн
Avg. vol.
62,80 мың
Volume
104,91 м.
52-wk high
0,95 $
52-wk low
0,38 $
EPS
-0,78 $
Beta
1,97
Shares outstanding
77,40 млн
No. of employees
45
News stories
From web sources and news partners
About Envoy Medical Inc
CEO-
Employees45
Founded1995
Headquarters-
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to COCH in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for COCH in the last 3 months.
Highest
Current 0,64 $
2,50 $ (+292,28%)
Average
2,17 $ (+240,50%)
Lowest
2,00 $ (+213,82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
2,00 $
+213,8%
10/13/2026
Frank Takkinen
Lake Street
Buy
Initiated
2,50 $
+292,3%
10/06/2026
Alexander Nowak
Lucid Capital
Buy
Initiated
2,00 $
+213,8%
07/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
42,00 мың
75,00 мың
39,00 мың
51,00 мың
Cost of goods sold
203,00 м.
21,00 мың
313,00 м.
278,00 м.
Cost of revenue
203,00 м.
21,00 мың
313,00 м.
278,00 м.
Research and development expenses
2,70 млн
4,55 млн
3,64 млн
3,13 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,85 млн
1,70 млн
2,04 млн
2,21 млн
Operating expense
5,55 млн
6,25 млн
5,68 млн
5,34 млн
Total operating expenses
5,75 млн
6,27 млн
6,00 млн
5,62 млн
Operating income
-5,71 млн
-6,20 млн
-5,96 млн
-5,57 млн
Other non operating income
-303,00 м.
-201,00 м.
1,61 млн
-413,00 м.
EBT including unusual items
-6,48 млн
-6,59 млн
-4,35 млн
-5,98 млн
EBT excluding unusual items
-6,48 млн
-6,40 млн
-4,35 млн
-5,98 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6,48 млн
-6,59 млн
-4,35 млн
-5,98 млн
Net profit margin
-15 433,33%
-8 781,33%
-11 156,41%
-11 729,41%
Earnings per share
-0,35
-
-0,08
-0,07
Interest and investment income
-
-
-
-
Interest expense
-471,00 м.
-
-
-
Net interest expenses
-471,00 м.
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,63 млн
-6,12 млн
-5,89 млн
-5,50 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары